Cargando…

Quantitative assessment of engineered Cas9 variants for target specificity enhancement by single-molecule reaction pathway analysis

There have been many engineered Cas9 variants that were developed to minimize unintended cleavage of off-target DNAs, but detailed mechanism for the way they regulate the target specificity through DNA:RNA heteroduplexation remains poorly understood. We used single-molecule FRET assay to follow the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bak, So Young, Jung, Youngri, Park, Jinho, Sung, Keewon, Jang, Hyeon-Ki, Bae, Sangsu, Kim, Seong Keun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565309/
https://www.ncbi.nlm.nih.gov/pubmed/34554247
http://dx.doi.org/10.1093/nar/gkab858
_version_ 1784593798746079232
author Bak, So Young
Jung, Youngri
Park, Jinho
Sung, Keewon
Jang, Hyeon-Ki
Bae, Sangsu
Kim, Seong Keun
author_facet Bak, So Young
Jung, Youngri
Park, Jinho
Sung, Keewon
Jang, Hyeon-Ki
Bae, Sangsu
Kim, Seong Keun
author_sort Bak, So Young
collection PubMed
description There have been many engineered Cas9 variants that were developed to minimize unintended cleavage of off-target DNAs, but detailed mechanism for the way they regulate the target specificity through DNA:RNA heteroduplexation remains poorly understood. We used single-molecule FRET assay to follow the dynamics of DNA:RNA heteroduplexation for various engineered Cas9 variants with respect to on-target and off-target DNAs. Just like wild-type Cas9, these engineered Cas9 variants exhibit a strong correlation between their conformational structure and nuclease activity. Compared with wild-type Cas9, the fraction of the cleavage-competent state dropped more rapidly with increasing base-pair mismatch, which gives rise to their enhanced target specificity. We proposed a reaction model to quantitatively analyze the degree of off-target discrimination during the successive process of R-loop expansion. We found that the critical specificity enhancement step is activated during DNA:RNA heteroduplexation for evoCas9 and HypaCas9, while it occurs in the post-heteroduplexation stage for Cas9-HF1, eCas9, and Sniper-Cas9. This study sheds new light on the conformational dynamics behind the target specificity of Cas9, which will help strengthen its rational designing principles in the future.
format Online
Article
Text
id pubmed-8565309
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-85653092021-11-04 Quantitative assessment of engineered Cas9 variants for target specificity enhancement by single-molecule reaction pathway analysis Bak, So Young Jung, Youngri Park, Jinho Sung, Keewon Jang, Hyeon-Ki Bae, Sangsu Kim, Seong Keun Nucleic Acids Res RNA and RNA-protein complexes There have been many engineered Cas9 variants that were developed to minimize unintended cleavage of off-target DNAs, but detailed mechanism for the way they regulate the target specificity through DNA:RNA heteroduplexation remains poorly understood. We used single-molecule FRET assay to follow the dynamics of DNA:RNA heteroduplexation for various engineered Cas9 variants with respect to on-target and off-target DNAs. Just like wild-type Cas9, these engineered Cas9 variants exhibit a strong correlation between their conformational structure and nuclease activity. Compared with wild-type Cas9, the fraction of the cleavage-competent state dropped more rapidly with increasing base-pair mismatch, which gives rise to their enhanced target specificity. We proposed a reaction model to quantitatively analyze the degree of off-target discrimination during the successive process of R-loop expansion. We found that the critical specificity enhancement step is activated during DNA:RNA heteroduplexation for evoCas9 and HypaCas9, while it occurs in the post-heteroduplexation stage for Cas9-HF1, eCas9, and Sniper-Cas9. This study sheds new light on the conformational dynamics behind the target specificity of Cas9, which will help strengthen its rational designing principles in the future. Oxford University Press 2021-09-23 /pmc/articles/PMC8565309/ /pubmed/34554247 http://dx.doi.org/10.1093/nar/gkab858 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle RNA and RNA-protein complexes
Bak, So Young
Jung, Youngri
Park, Jinho
Sung, Keewon
Jang, Hyeon-Ki
Bae, Sangsu
Kim, Seong Keun
Quantitative assessment of engineered Cas9 variants for target specificity enhancement by single-molecule reaction pathway analysis
title Quantitative assessment of engineered Cas9 variants for target specificity enhancement by single-molecule reaction pathway analysis
title_full Quantitative assessment of engineered Cas9 variants for target specificity enhancement by single-molecule reaction pathway analysis
title_fullStr Quantitative assessment of engineered Cas9 variants for target specificity enhancement by single-molecule reaction pathway analysis
title_full_unstemmed Quantitative assessment of engineered Cas9 variants for target specificity enhancement by single-molecule reaction pathway analysis
title_short Quantitative assessment of engineered Cas9 variants for target specificity enhancement by single-molecule reaction pathway analysis
title_sort quantitative assessment of engineered cas9 variants for target specificity enhancement by single-molecule reaction pathway analysis
topic RNA and RNA-protein complexes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565309/
https://www.ncbi.nlm.nih.gov/pubmed/34554247
http://dx.doi.org/10.1093/nar/gkab858
work_keys_str_mv AT baksoyoung quantitativeassessmentofengineeredcas9variantsfortargetspecificityenhancementbysinglemoleculereactionpathwayanalysis
AT jungyoungri quantitativeassessmentofengineeredcas9variantsfortargetspecificityenhancementbysinglemoleculereactionpathwayanalysis
AT parkjinho quantitativeassessmentofengineeredcas9variantsfortargetspecificityenhancementbysinglemoleculereactionpathwayanalysis
AT sungkeewon quantitativeassessmentofengineeredcas9variantsfortargetspecificityenhancementbysinglemoleculereactionpathwayanalysis
AT janghyeonki quantitativeassessmentofengineeredcas9variantsfortargetspecificityenhancementbysinglemoleculereactionpathwayanalysis
AT baesangsu quantitativeassessmentofengineeredcas9variantsfortargetspecificityenhancementbysinglemoleculereactionpathwayanalysis
AT kimseongkeun quantitativeassessmentofengineeredcas9variantsfortargetspecificityenhancementbysinglemoleculereactionpathwayanalysis